Oncology Nutrition Market to Surpass US$ 4.79 Bn by 2032: Rising Demand to Promote Cancer Patients'' Quality of Life to Boost Growth | Future Market Insights, Inc.
The oncology nutrition market in the United States is expected to be worth US$ 412.6 million. The U.S. presently holds 35.62% of the global oncology nutrition market share. Demand for oncology nutrition is predicted to increase in the United States, fueled by rising spending on various cancer medicines. NEWARK, DE | ACCESSWIRE | September 26, 2022 | The adoption of oncology nutrition is likely to grow at an average CAGR of 8.9% during the forecast period. The oncology nutrition market size is estimated to be valued at US$ 2.04 Bn in 2022 and is projected to be valued at US$ 4.79 Bn by 2032. The significant increase in nutritional waste and risk among cancer patients is expected to boost the demand for oncology nutrition. Participants in the market environment are currently examining the potential benefits of a multidisciplinary strategy, where concentrated nutrition is believed to be critical to enhancing cancer treatment standards. Over the estimated period, the oncology nutrition market is expected to benefit from increasing research and development efforts as well as the launch of cutting-edge products for cancer patients.
Oncology Nutrition Market to Surpass US$ 4.79 Bn by 2032: Rising Demand to Promote Cancer Patients'' Quality of Life to Boost Growth | Future Market Insights, Inc.
The oncology nutrition market in the United States is expected to be worth US$ 412.6 million. The U.S. presently holds 35.62% of the global oncology nutrition market share. Demand for oncology nutrition is predicted to increase in the United States, fueled by rising spending on various cancer medicines. NEWARK, DE | ACCESSWIRE | September 26, 2022 | The adoption of oncology nutrition is likely to grow at an average CAGR of 8.9% during the forecast period. The oncology nutrition market size is estimated to be valued at US$ 2.04 Bn in 2022 and is projected to be valued at US$ 4.79 Bn by 2032. The significant increase in nutritional waste and risk among cancer patients is expected to boost the demand for oncology nutrition. Participants in the market environment are currently examining the potential benefits of a multidisciplinary strategy, where concentrated nutrition is believed to be critical to enhancing cancer treatment standards. Over the estimated period, the oncology nutrition market is expected to benefit from increasing research and development efforts as well as the launch of cutting-edge products for cancer patients.